Australia, July 14 -- TFI BV Pty Ltd (ACN: 095104028) has issued a ‘NOTICE OF FIRST MEETING OF CREDITORS OF COMPANY UNDER ADMINISTRATION (COMBINED) - 436E(3)(b)’ on July 13. The following are other re... Read More
Tokyo, July 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062226) titled 'Evaluation of a Positional Cranial Deformity Prevention Program for Preterm... Read More
Tokyo, July 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062225) titled 'Feasibility Study of an Online Psychoeducation Program for Parents of Adole... Read More
Tokyo, July 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062224) titled 'An observational study using proteome analysis in VEGF inhibitor-induced pr... Read More
Tokyo, July 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062209) titled 'Safe Liberation from V-A ECMO with Pump-Controlled Retrograde Trial Off ver... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127992) titled 'The Impact of Carbon Dioxide on the Prognosis of Patients with Atheroscle... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127996) titled 'Study on the efficacy and safety of bupivacaine liposome combined with ro... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127990) titled 'A comparative clinical study on the effect of dapagliflozin combined with... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127994) titled 'Clinical value of a follow-up intervention strategy based on multimodal i... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127991) titled 'A phase II clinical study of briitinib in combination with PLB1004 first-... Read More